Immunogenicity and Efficacy Testing of Ad26.Filo/MVA-BN-Filo Prime-Boost Vaccine Regimens in Nonhuman Primates against Ebola Virus Challenge.

Project: Other project

Project Details

StatusFinished
Effective start/end date5/23/196/30/20

Funding

  • Janssen Vaccines and Prevention BV: $146,418.00